Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Experience with sotrovimab treatment of SARS‐CoV‐2‐infected patients in Denmark
Line Dahlerup Rasmussen, Anne‐Mette Lebech, Anne Øvrehus, et al.
British Journal of Clinical Pharmacology (2022) Vol. 89, Iss. 6, pp. 1820-1833
Open Access | Times Cited: 11

Showing 11 citing articles:

Monoclonal Antibodies in Prevention and Early Treatment of COVID-19 in Lung Transplant Recipients: A Systematic Review and Perspective on the Role of Monoclonal Antibodies in the Future
David A. Van Eijndhoven, Robin Vos, Saskia Bos
Transplant International (2025) Vol. 38
Open Access
Clinical Practice Recommendations on the Effect of COVID‐19 Vaccination Strategies on Outcomes in Solid Organ Transplant Recipients
Farid Foroutan, Daniel Rayner, Shelly Oss, et al.
Clinical Transplantation (2025) Vol. 39, Iss. 2
Closed Access
Real-world effectiveness of sotrovimab for the treatment of SARS-CoV-2 infection during Omicron BA.2 and BA.5 subvariant predominance: a systematic literature review
Myriam Drysdale, Mehmet Berktaş, Daniel C. Gibbons, et al.
Infection (2024) Vol. 52, Iss. 5, pp. 1839-1861
Open Access | Times Cited: 4
Efficacy and safety of COVID-19 vaccination in solid organ transplant recipients: A systematic review and network meta-analysis
Daniel Rayner, Jairo Tavares Nunes, David Gou, et al.
American Journal of Transplantation (2024) Vol. 24, Iss. 12, pp. 2269-2281
Open Access | Times Cited: 4
Antiviral activities of sotrovimab against BQ.1.1 and XBB.1.5 in sera of treated patients
Timothée Bruel, Lou-Léna Vrignaud, Françoise Porrot, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 7
Omicron related COVID-19 prevention and treatment measures for patients with hematological malignancy and strategies for modifying hematologic treatment regimes
Wenjing Guo, Yizhou Zheng, Sizhou Feng
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 7
Characteristics and outcomes of patients treated with sotrovimab to prevent progression to severe COVID-19 in Belgium
Myriam Drysdale, Thor Hautekiet, Moushmi Singh, et al.
Acta Clinica Belgica (2024) Vol. 79, Iss. 3, pp. 174-183
Open Access
Clinical practice guideline supported administration of monoclonal antibody therapy for high-risk patients with COVID-19: Experience of a quaternary care centre
K. Hammond, François Bourdeau, Marina Klein, et al.
Journal of the Association of Medical Microbiology and Infectious Disease Canada (2024)
Closed Access
Coronavirus Disease 2019 (COVID-19) in Heart Transplant Recipients and Anti-SARS-CoV-2 Monoclonal Antibodies: Experience, Lessons Learnt, and Future Challenges
Rohan Kapur, Kenji Okumura, Suguru Ohira, et al.
Cardiology in Review (2024)
Closed Access
Real-world effectiveness of sotrovimab for the treatment of SARS-CoV-2 infection during Omicron BA.2 and BA.5 subvariant predominance: a systematic literature review
Myriam Drysdale, Mehmet Berktaş, Daniel C. Gibbons, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Characteristics and outcomes of patients treated with sotrovimab to prevent progression to severe COVID-19 in Belgium
Myriam Drysdale, Thor Hautekiet, Moushmi Singh, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Page 1

Scroll to top